Crossmark

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies

Crossref DOI link: https://doi.org/10.1186/s40169-018-0213-6

Published Online: 2018-11-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jacot, Terry A.

Clark, Meredith R.

Adedipe, Oluwatosin E.

Godbout, Susan

Peele, Abby G.

Ju, Susan

Schwartz, Jill L.

Thurman, Andrea R.

Doncel, Gustavo F.
Funding

Funding for this research was provided by:

U.S. President’s Emergency Plan for AIDS Relief

United States Agency for International Development

Eastern Virginia Medical School

Bill & Melinda Gates Foundation (OPP1114939)

United States Agency for International Development (AID-OAA-A-14-00005)
License Information

Version of Record valid from 2018-11-07

Text and Data Mining valid from 2018-11-07

Version of Record valid from 2018-11-07
More Information

Article History

Received: 17 July 2018

Accepted: 24 October 2018

First Online: 7 November 2018